These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9831079

  • 21. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells.
    Kongsbak M, von Essen MR, Boding L, Levring TB, Schjerling P, Lauritsen JP, Woetmann A, Ødum N, Bonefeld CM, Geisler C.
    PLoS One; 2014; 9(5):e96695. PubMed ID: 24792400
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS.
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ.
    Cancer Res; 2000 Apr 15; 60(8):2247-52. PubMed ID: 10786691
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.
    Ellison TI, Dowd DR, MacDonald PN.
    Mol Endocrinol; 2005 Sep 15; 19(9):2309-19. PubMed ID: 15919723
    [Abstract] [Full Text] [Related]

  • 30. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.
    Arbour NC, Prahl JM, DeLuca HF.
    Mol Endocrinol; 1993 Oct 15; 7(10):1307-12. PubMed ID: 8264662
    [Abstract] [Full Text] [Related]

  • 31. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep 15; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mouse homologue of yeast Prp19 interacts with mouse SUG1, the regulatory subunit of 26S proteasome.
    Sihn CR, Cho SY, Lee JH, Lee TR, Kim SH.
    Biochem Biophys Res Commun; 2007 Apr 27; 356(1):175-80. PubMed ID: 17349974
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence that proteolysis of Gal4 cannot explain the transcriptional effects of proteasome ATPase mutations.
    Russell SJ, Johnston SA.
    J Biol Chem; 2001 Mar 30; 276(13):9825-31. PubMed ID: 11152478
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P, Barmina O, Chang CY, McDonnell DP, Shevde NK, Pike JW.
    J Bone Miner Res; 2002 Dec 30; 17(12):2196-205. PubMed ID: 12469913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.